Cytologically indeterminate thyroid nodules remain a diagnostic and clinical challenge, and
molecular testing has been advocated and advanced as a diagnostic modality to help guide …

It is unequivocally recognized that thyroid nodules are frequently detected in the adult
population and mostly characterized by benign lesions (up to 70% of them), with only 5 …

Hürthle cell thyroid carcinoma (HTC) accounts for 3–5% of all thyroid malignancies. Widely
invasive HTC is characterized by poor prognosis and limited responsiveness to standard …

In fine-needle aspirations (FNA) of thyroid, Hürthle cells can be found in a broad spectrum of
lesions, ranging from non-neoplastic conditions to aggressive malignant tumors. Recognize …

Objectives Hürthle cells are a common finding on thyroid fine-needle aspiration, but when
they are the predominant cytology, they represent a difficult diagnostic challenge. The …

As the value of molecular testing of cancer specimens increases, the number of tests
imposed on tumor specimens also increases, often in tension with the amount of tumor …

The EIF1AX gene mutations have been recently associated with papillary thyroid carcinoma
and anaplastic thyroid cancer. According with these reports, the gene as been considered …

Indeterminate cytopathology has been a major clinical challenge in the identification of
malignancy in thyroid nodules by fine-needle aspiration. Diagnostic lobectomy has long …

Fine needle aspiration cytology/biopsy (FNAB) is quite often one of the first tests for the initial
evaluation of lesions/swellings which are accessible to the needle tracts. The technique has …

Follicular Neoplasm Hürthle Cell (Oncocytic) Type/Suspicious for Follicular Neoplasm Hürthle
Cell (Oncocytic) Type | SpringerLink Skip to main content Advertisement SpringerLink Account …